Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome and its relationship with blood pressure, blood glucose and blood lipid

Xiao,Peng; Song,Wei; Han,Zhe

doi:10.3892/etm.2018.6839

Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome and its relationship with blood pressure, blood glucose and blood lipid

Authors:
- Peng Xiao
- Wei Song
- Zhe Han
View Affiliations

Affiliations: Department of Thoracic Surgery, Luoyang Center Hospital Affiliated to Zhengzhou University, Luoyang, Henan 471009, P.R. China, Department of Cardiac Surgery, The Second People's Hospital of Liaocheng, Linqing, Shandong 252600, P.R. China, Department of Cardiac Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China
Published online on: October 9, 2018 https://doi.org/10.3892/etm.2018.6839
Pages: 5003-5008
Copyright: © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome (MS) and its relationships with blood pressure, blood glucose and blood lipid were investigated. Clinical data of 126 patients were retrospectively analyzed, and patients were divided into infection group (n=19) and non-infection group (n=107). The differences of MS components in patients between the two groups were compared, and the distribution of pathogens and related factors of pulmonary infection were analyzed. The postoperative pulmonary infection rate was 15.08% (19/126); the body mass index (BMI), blood pressure, fasting blood glucose (FBG), triglyceride, total cholesterol, low-density lipoprotein cholesterol, the extubation time of trachea cannula, ventilator use time, rethoracotomy hemostasis rate, sternal dehiscence rate and incidence of low-cardiac-output syndrome were higher and high-density lipoprotein (HDL-C), left ventricular ejection fraction (LVEF) was lower in the infection group than that in the non-infection group (p<0.05). The rate of postoperative pulmonary infection in patients with MS was higher than in those without MS (p<0.05). Cardiac function, BMI, FBG, HDL-C, LVEF value, extubation time of trachea cannula, ventilator use time, sternal dehiscence, rethoracotomy hemostasis and low-cardiac-output syndrome were independent risk factors for pulmonary infection after mitral valve repair in patients with MS. In conclusion, pulmonary infection easily occurs in patients with MS after mitral valve repair. Taking intervention measures according to the characteristics of pulmonary infection pathogens and predisposing factors is expected to reduce the incidence of pulmonary infection.

View Figures

View References

1	Blasi A, Muñoz G, de Soto I, Mellado R, Taura P, Rios J, Balust J and Beltran J: Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement. Thromb Res. 136:669–672. 2015. View Article : Google Scholar : PubMed/NCBI
2	Weber B and Hoerstrup SP: The future of heart valve replacement. Eur Heart J. 36:326–328. 2015.PubMed/NCBI
3	Zhang XW, Song ZG, Wang L, Lu FL, Zou LJ, Xu JB and Xu ZY: The use of intra-aortic balloon pump in patients undergoing heart valve replacement: Outcome and risk analysis. J Heart Valve Dis. 23:458–462. 2014.PubMed/NCBI
4	Weimar T, Roser D, Liebrich M, Horke A, Doll N and Hemmer WB: Strategies for biological heart valve replacement: Stentless xenografts fail to evolve into an alternative pulmonary valve substitute in a Ross procedure. Biotechnol J. 8:345–351. 2013. View Article : Google Scholar : PubMed/NCBI
5	Eckle RH, Grundy SM and Zimmet PZ: The metabolism syndrome. Lancet. 365:1415–1428. 2005. View Article : Google Scholar : PubMed/NCBI
6	Li DL, Dong PS, Du LJ, Li ZZ, Sh XY and Fan XM: Analysis of related risk factors of pulmonary infection after heart valve replacement. J Hosp Infect. 23:3908–3910. 2013.
7	Metabolic syndrome study group of Chinese Diabetes Association. Recommendations of the Chinese Medical Association Diabetes Branch on metabolic syndrome. Chin J Diabetes Mellitus. 12:156–161. 2004.(In Chinese).
8	Riera M, Ibáñez J, Herrero J, Ignacio Sáez De Ibarra J, Enríquez F, Campillo C and Bonnín O: Respiratory tract infections after cardiac surgery: Impact on hospital morbidity and mortality. J Cardiovasc Surg (Torino). 51:907–914. 2010.PubMed/NCBI
9	Salazar MR, Carbajal HA, Espeche WG, Dulbecco CA, Aizpurúa M, Marillet AG, Echeverría RF and Reaven GM: Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res. 8:109–116. 2011. View Article : Google Scholar : PubMed/NCBI
10	Suemitsu R, Sakoguchi T, Morikawa K, Yamaguchi M, Tanaka H and Takeo S: Effect of body mass index on perioperative complications in thoracic surgery. Asian Cardiovasc Thorac Ann. 16:463–467. 2008. View Article : Google Scholar : PubMed/NCBI
11	Lola I, Levidiotou S, Petrou A, Arnaoutoglou H, Apostolakis E and Papadopoulos GS: Are there independent predisposing factors for postoperative infections following open heart surgery? J Cardiothorac Surg. 6:1512011. View Article : Google Scholar : PubMed/NCBI
12	Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T and Schricker T: The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 95:4338–4344. 2010. View Article : Google Scholar : PubMed/NCBI
13	Hu QG and Zheng QC: The influence of enteral nutrition in postoperative patients with poor liver function. World J Gastroenterol. 9:843–846. 2003. View Article : Google Scholar : PubMed/NCBI
14	Murphy AJ, Chin-Dusting JP, Sviridov D and Woollard KJ: The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 16:667–675. 2009. View Article : Google Scholar : PubMed/NCBI
15	Habal P, Simek J and Stĕtina M: Improving of treatment safety in emergency thoracic surgery. Rozhl Chir. 89:261–264. 2010.(In Czech). PubMed/NCBI
16	Zhang C, Gao J and He B: Analysis of related factors of patientos undergoing cardiac valve replacement complicated with pulmonary infection and nursing strategies of it. Chin Nurs Res. 90:64–66. 2008.
17	Weimar T, Roser D, Liebrich M, Horke A, Doll N and Hemmer WB: Strategies for biological heart valve replacement: Stentless xenografts fail to evolve into an alternative pulmonary valve substitute in a Ross procedure. Biotechnol J. 8:345–351. 2013. View Article : Google Scholar : PubMed/NCBI
18	Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, Van Lingen A, Fioretti PM and Visser CA: Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med. 42:79–86. 2001.PubMed/NCBI
19	Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, et al: Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: A comparison with the Sapien XT. JACC Cardiovasc Interv. 8:462–471. 2015. View Article : Google Scholar : PubMed/NCBI
20	Phan K, Tsai YC, Niranjan N, Bouchard D, Carrel TP, Dapunt OE, Eichstaedt HC, Fischlein T, Gersak B, Glauber M, et al: Sutureless aortic valve replacement: A systematic review and meta-analysis. Ann Cardiothorac Surg. 4:100–111. 2015.PubMed/NCBI
21	Cai XH: Risk factors for nosocomial pulmonary infection after tracheal intubation under general anesthesia. Chin J Nosocomiology. 9:1780–1782. 2011.(In Chinese).
22	Flynn DM, Weinstein RA and Kabins SA: Infections with gram-negative bacilli in a cardiac surgery intensive care unit: the relative role of enterobacter. J Hosp Infect. 11 Suppl A:367–373. 1988. View Article : Google Scholar : PubMed/NCBI
23	Farran L, Llop J, Sans M, Kreisler E, Miró M, Galan M and Rafecas A: Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. Dis Esophagus. 21:159–164. 2008. View Article : Google Scholar : PubMed/NCBI
24	Miljeteig I, Skrede S, Langørgen J, Haaverstad R, Jøsendal O, Sjursen H and Norheim OF: Should patients who use illicit drugs be offered a second heart-valve replacement? Tidsskr Nor Laegeforen. 133:977–980. 2013.(In Norwegian). View Article : Google Scholar : PubMed/NCBI
25	Berg SK, Zwisler AD, Pedersen BD, Haase K and Sibilitz KL: Patient experiences of recovery after heart valve replacement: Suffering weakness, struggling to resume normality. BMC Nurs. 12:232013. View Article : Google Scholar : PubMed/NCBI
26	Nietlispach F and Maisano F: Balloon post-dilation after transcatheter aortic valve replacement: A solution worth trying in patients with residual aortic insufficiency. JACC Cardiovasc Interv. 7:790–791. 2014. View Article : Google Scholar : PubMed/NCBI